(lincomycin) TYPE A MEDICATED ARTICLE
HEALTHIER PIGS. IMPROVED ECONOMIC OUTCOMES.
Mycoplasma hyopneumoniae (M. hyopneumoniae) has challenged swine veterinarians and producers for decades, and the disease remains a legitimate challenge. Various surveys suggest U.S. herd prevalence exceeds 50%,1 and according to recent research from Iowa State University, M. hyopneumoniae was the third-most common cause of swine pneumonia from 2003 to 2014.
LINCOMIX from Zoetis is now approved at a range of 100 to 200 grams per ton for the reduction in severity of effects of respiratory disease associated with M. hyopneumoniae. It is the only U.S. Type A Medicated Article with an approved M. hyopneumoniae claim. When the product is administered at 100 g/ton, producers and veterinarians can also control ileitis.
CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
1 Thacker EL, Minion FC. Mycoplasmosis. In: Zimmerman JJ, Karriker LA, Ramirez A, et al, eds. Diseases of Swine, 10th ed. Oxford, UK: Wiley-Blackwell; 2012:779-797.